CEACAM5 and colorectal carcinoma: With this prospective, single institution study, we aimed to the detection and comparison of CEACAM5-positive CTCs with microbial DNA detection which could be originated from the intestine, in the blood of patients with stage III CRC under three versus 6 months of chemotherapy.